Search

Your search keyword '"Paul Angaran"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Paul Angaran" Remove constraint Author: "Paul Angaran"
98 results on '"Paul Angaran"'

Search Results

1. Centre-Specific Variation in Atrial Fibrillation Ablation-Treatment Rates in a Universal Single-Payer Healthcare System

2. ICD Implantation Rates in Cardiac Arrest Survivors in Canada

3. Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care

4. Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators

5. Sex Differences and Utility of Treadmill Testing in Long‐QT Syndrome

6. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

7. Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes

8. The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network

9. Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada

11. Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction

12. Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathy

13. Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

14. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

15. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

16. 2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist

17. Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators

18. Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence

19. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

20. The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network

21. 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease

22. Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale

23. Importance of genetic testing in unexplained cardiac arrest

24. Relationship Between Left Ventricular Strain Assessment by Cardiac Magnetic Resonance Imaging and Response to Cardiac Resynchronization Therapy

25. Return of Results Policies for Genomic Research: Current Practices and the Hearts in Rhythm Organization (HiRO) Approach

26. Challenge and Impact of Quinidine Access in Sudden Death Syndromes

27. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices

28. Prevention of Arrhythmia Device Infection Trial

29. Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories

30. LONG-TERM ARRHYTHMIC OUTCOMES AMONG CARDIAC ARREST SURVIVORS WITH PRESERVED EJECTION FRACTION REGISTRY (CASPER)

31. Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada

32. Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators

33. Impact of Choice of Prophylaxis on the Microbiology of Cardiac Implantable Electronic Device Infections: Insights From the Prevention of Arrhythmia Device Infection Trial (PADIT)

34. Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes

35. B-PO01-020 MACHINE LEARNING TO PREDICT RECURRENT EVENTS FOLLOWING UNEXPLAINED CARDIAC ARREST

36. B-011-22 MACHINE LEARNING TO PREDICT RECURRENT EVENTS FOLLOWING UNEXPLAINED CARDIAC ARREST

37. Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry

38. Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trial

39. Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia

40. CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist

41. Non-arrhythmic pre-excitation-induced cardiomyopathy

42. Rhythm and rate control of atrial fibrillation in the emergency department – A large community-based observational study

43. Implantable Cardioverter Defibrillator Implantation Rates After Out of Hospital Cardiac Arrest: Are the Rates Guideline-Concordant?

44. Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation

45. VARIANT RE-INTERPRETATION IN SURVIVORS OF CARDIAC ARREST WITH PRESERVED EJECTION FRACTION (CASPER REGISTRY) BY CLINICIANS AND CLINICAL COMMERCIAL LABORATORIES

46. Natural History of Left Ventricular Thrombi in Patients with Cardiomyopathy

47. Correction

48. Association of Left Ventricular Ejection Fraction with Mortality and Hospitalizations

49. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome

50. Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction

Catalog

Books, media, physical & digital resources